[1] World Health Organization. Weekly epidemiological update on covid-19 - 16 March 2023. 2023. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---16-march-2023. [2024-3-18].
[2] Shrestha LB, Foster C, Rawlinson W, Tedla N, Bull RA. Evolution of the SARS-CoV-2 omicron variants BA. 1 to BA.5: implications for immune escape and transmission. Rev Med Virol 2022;32(5):e2381. https://doi.org/10.1002/rmv.2381CrossRef
[3] Asadi S, Bouvier N, Wexler AS, Ristenpart WD. The coronavirus pandemic and aerosols: does COVID-19 transmit via expiratory particles?. Aerosol Sci Technol 2020;54(6):635 − 8. https://doi.org/10.1080/02786826.2020.1749229CrossRef
[4] Kucirka LM, Lauer SA, Laeyendecker O, Boon D, Lessler J. Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure. Ann Intern Med 2020;173(4):262 − 7. https://doi.org/10.7326/M20-1495CrossRef
[5] Brummer LE, Katzenschlager S, Gaeddert M, Erdmann C, Schmitz S, Bota M, et al. Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: a living systematic review and meta-analysis. PLoS Med 2021;18(8):e1003735. https://doi.org/10.1371/journal.pmed.1003735CrossRef
[6] Khalid MF, Selvam K, Jeffry AJN, Salmi MF, Najib MA, Norhayati MN, et al. Performance of rapid antigen tests for COVID-19 diagnosis: a systematic review and meta-analysis. Diagnostics (Basel) 2022;12(1):110. https://doi.org/10.3390/diagnostics12010110CrossRef
[7] Ye Q, Shao WX, Meng HY. Performance and application evaluation of SARS-CoV-2 antigen assay. J Med Virol 2022;94(8):3548 − 53. https://doi.org/10.1002/jmv.27798CrossRef
[8] Greub G, Caruana G, Schweitzer M, Imperiali M, Muigg V, Risch M, et al. Multicenter technical validation of 30 rapid antigen tests for the detection of SARS-CoV-2 (VALIDATE). Microorganisms 2021;9(12):2589. https://doi.org/10.3390/microorganisms9122589CrossRef
[9] Kohmer N, Toptan T, Pallas C, Karaca O, Pfeiffer A, Westhaus S, et al. The comparative clinical performance of four SARS-CoV-2 rapid antigen tests and their correlation to infectivity in vitro. J Clin Med 2021;10(2):328. https://doi.org/10.3390/jcm10020328CrossRef
[10] Navero-Castillejos J, Casals-Pascual C, Narváez S, Cuesta G, Hurtado JC, Fernandez M, et al. Diagnostic performance of six rapid antigen tests for SARS-CoV-2. Microbiol Spectr 2022;10(2):e02351 − 21. https://doi.org/10.1128/spectrum.02351-21CrossRef
[11] Wu C, Qavi AJ, Hachim A, Kavian N, Cole AR, Moyle AB, et al. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain. iScience 2021;24(6):102681. https://doi.org/10.1016/j.isci.2021.102681CrossRef
[12] Pu YY, Weng YH, Wu YH, Gao F, Zheng XJ, Xiong XQ, et al. Antibody response to SARS-CoV-2 in the first batch of COVID-19 patients in China by a self-developed rapid IgM-IgG test. Front Cell Infect Microbiol 2022;12:915751. https://doi.org/10.3389/fcimb.2022.915751CrossRef
[13] Dinnes J, Deeks JJ, Adriano A, Berhane S, Davenport C, Dittrich S, et al. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection. Cochrane Database Syst Rev 2020;8(8):CD013705. https://doi.org/10.1002/14651858.CD013705CrossRef
[14] Regev-Yochay G, Kriger O, Mina MJ, Beni S, Rubin C, Mechnik B, et al. Real world performance of SARS-CoV-2 antigen rapid diagnostic tests in various clinical settings. Infect Control Hosp Epidemiol 2022:1-20. http://dx.doi.org/10.1017/ice.2022.3.
[15] Scheiblauer H, Filomena A, Nitsche A, Puyskens A, Corman VM, Drosten C, et al. Comparative sensitivity evaluation for 122 CE-marked rapid diagnostic tests for SARS-CoV-2 antigen, Germany, September 2020 to April 2021. Euro Surveill 2021;26(44):2100441. https://doi.org/10.2807/1560-7917.ES.2021.26.44.2100441CrossRef
[16] Schuit E, Venekamp RP, Veldhuijzen IK, van den Bijllaardt W, Pas SD, Stohr JJJM, et al. Head-to-head comparison of the accuracy of saliva and nasal rapid antigen SARS-CoV-2 self-testing: cross-sectional study. BMC Med 2022;20(1):406. https://doi.org/10.1186/s12916-022-02603-xCrossRef
[17] Samsunder N, Lustig G, de Vos M, Ngcapu S, Giandhari J, Tshiabuila D, et al. Performance of rapid antigen tests in identifying Omicron BA. 4 and BA.5 infections in South Africa. J Clin Virol 2023;165:105498. https://doi.org/10.1016/j.jcv.2023.105498CrossRef
[18] Tom MR, Mina MJ. To interpret the SARS-CoV-2 test, consider the cycle threshold value. Clin Infect Dis 2020;71(16):2252 − 4. https://doi.org/10.1093/cid/ciaa619CrossRef
[19] Bullard J, Dust K, Funk D, Strong JE, Alexander D, Garnett L, et al. Predicting infectious severe acute respiratory syndrome coronavirus 2 from diagnostic samples. Clin Infect Dis 2020;71(10):2663 − 6. https://doi.org/10.1093/cid/ciaa638CrossRef
[20] Igloi Z, Velzing J, van Beek J, van de Vijver D, Aron G, Ensing R, et al. Clinical evaluation of Roche SD biosensor rapid antigen test for SARS-CoV-2 in municipal health service testing site, the Netherlands. Emerg Infect Dis 2021;27(5):1323 − 9. https://doi.org/10.3201/eid2705.204688CrossRef
[21] Jääskeläinen AE, Ahava MJ, Jokela P, Szirovicza L, Pohjala S, Vapalahti O, et al. Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection. J Clin Virol 2021;137:104785. https://doi.org/10.1016/j.jcv.2021.104785CrossRef
[22] Smith RD, Johnson JK, Clay C, Girio-Herrera L, Stevens D, Abraham M, et al. Clinical evaluation of Sofia rapid antigen assay for detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) among emergency department to hospital admissions. Infect Control Hosp Epidemiol 2022;43(8):968 − 73. https://doi.org/10.1017/ice.2021.281CrossRef